ArticleFrontiers in medicine2026
Development and validation of a CT-based habitat radiomics model for predicting pathological grading in non-small cell lung cancer.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Radiomics: Current Applications and Future Directions.MedComm · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop and validate models for predicting pathological grading of non-small cell lung cancer (NSCLC) using habitat radiomics and clinical semantic features. Materials and methods: In this retrospective study of 800 NSCLC patients, a whole tumor volume (WTV) was delineated by applying a 3 mm expansion to the gross tumor volume (GTV) on non-contrast CT scans. Habitat subregions within the WTV were identified using K-means clustering. A two-step binary classification model was constructed to predict pathological grades: Model-1 distinguished Grade 3 from combined Grades 1-2, and Model-2 further differentiated Grade 1 from Grade 2. Predictive models were built with logistic regression based on four distinct feature sets: WTV radiomics (Clf WVOI), habitat radiomics (Clf Habitats), clinical features (Clf Clinical), and a combined feature set (Clf Total). Results: In both Model-1 and Model-2, the classification performance of Clf Habitats was generally superior to that of Clf WVOI and Clf Clinical, achieving an AUC of 0.89 and 0.87, specificity of 0.73 for both models, and BACC of 0.78 and 0.79, respectively, on the test set. The combined model, Clf Total, achieved the best predictive performance on the test set, with AUC values of 0.91 and 0.88, specificity of 0.84 and 0.77, and BACC of 0.82 and 0.81. Conclusion: Habitat radiomics significantly improves NSCLC pathological grading. The multimodal model offers robust performance and high specificity, aiding personalized treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.